How Will the Market React to Vaxart Inc (VXRT) Stock Getting a Bearish Rating

Overall market sentiment has been down on Vaxart Inc (VXRT) stock lately. VXRT receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Vaxart Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VXRT!

See Full VXRT Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With VXRT Stock Today?

Vaxart Inc (VXRT) stock is up 7.78% while the S&P 500 is lower by -0.22% as of 2:06 PM on Tuesday, Oct 17. VXRT has gained $0.05 from the previous closing price of $0.67 on volume of 545,199 shares. Over the past year the S&P 500 has gained 18.65% while VXRT is lower by -59.78%. VXRT lost -$0.76 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Vaxart Inc click here.

More About Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. Click Here to get the full Stock Report for Vaxart Inc stock.